Info: Read More
  • 中药标准品生产商,产品定制服务
  • L-半胱氨酸

    L-Cysteine

    L-半胱氨酸
    产品编号 CFN70131
    CAS编号 52-90-4
    分子式 = 分子量 C3H7NO2S = 121.2
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Alkaloids
    植物来源
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    L-半胱氨酸 CFN70131 52-90-4 10mg QQ客服:2056216494
    L-半胱氨酸 CFN70131 52-90-4 20mg QQ客服:2056216494
    L-半胱氨酸 CFN70131 52-90-4 50mg QQ客服:2056216494
    L-半胱氨酸 CFN70131 52-90-4 100mg QQ客服:2056216494
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • Utrecht University (Netherlands)
  • Helmholtz Zentrum München (Germany)
  • Semmelweis Unicersity (Hungary)
  • Aarhus University (Denmark)
  • Universidade Federal de Goias (UFG) (Brazil)
  • Universiti Malaysia Pahang (Malaysia)
  • Leibniz Institute of Plant Biochemistry (Germany)
  • Julius Kühn-Institut (Germany)
  • Universita' Degli Studi Di Cagliari (Italy)
  • MTT Agrifood Research Finland (Finland)
  • John Innes Centre (United Kingdom)
  • Universidade Católica Portuguesa (Portugal)
  • Donald Danforth Plant Science Center (USA)
  • Washington State University (USA)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Pharmaceuticals (Basel).2024, 17(3):341.
  • Tissue Cell.2024, 88:102401.
  • Food Chem X.2024, 21:101208.
  • Int J Med Sci.2021, 18(10):2155-2161.
  • Korean J. Medicinal Crop Sci.2022, 30(2):117-123.
  • Acta Biochim Pol.2015, 62(2):253-8
  • Life (Basel).2021, 11(7):616.
  • J Bone Miner Res.2017, 32(12):2415-2430
  • J Pharm Biomed Anal2016, 118:183-194
  • Int J Mol Sci.2023, 24(18):14077.
  • Plants (Basel).2021, 10(12):2795.
  • Biomed Pharmacother.2020, 125:109784.
  • Advances in Traditional Medicine 2021, 21:779-789.
  • Molecules.2024, 29(5):1048.
  • Fermentation2023, 9(10), 889
  • National Academy Science Letters2023, s40009.
  • J Biomed Sci.2020, 27(1):60.
  • Exp Parasitol.2017, 183:160-166
  • J Pharmacol Sci.2021, 147(2):184-191.
  • Korean Journal of Pharmacognosy2018, 49(4):349-361
  • Chem Biol Interact.2019, 315:108910
  • RSC Advances2017, 86
  • Antioxidants (Basel).2021, 10(9):1487.
  • ...
  • 生物活性
    Description: L-Cysteine inhibits insulin release via multiple actions on the insulin secretory process through H(2)S production. L-Cysteine administration limits ischemia-reperfusion injury through a mechanism that appears to be at least partially dependent on H2S synthesis.
    In vitro:
    Diabetes, 2006, 55(5):1391.
    L-Cysteine Inhibits Insulin Release From the Pancreatic -Cell: Possible Involvement of Metabolic Production of Hydrogen Sulfide, a Novel Gasotransmitter[Reference: WebLink]
    Hydrogen sulfide (H(2)S) was historically recognized as a toxic gas generated by natural resources. However, its enzymatic production from L-cysteine has recently been demonstrated in mammals.
    METHODS AND RESULTS:
    Cystathionine beta-synthase and cystathionine gamma-lyase, both of which can produce H(2)S, were expressed in mouse pancreatic islet cells and the beta-cell line, MIN6. L-cysteine and the H(2)S donor NaHS inhibited glucose-induced insulin release from islets and MIN6 cells. These inhibitory effects were reproduced when insulin release was stimulated by alpha-ketoisocaproate, tolbutamide, or high K+. L-cysteine and NaHS inhibited glucose-potentiated insulin release in the copresence of diazoxide and high K+. Real-time imaging of intracellular Ca2+ concentration ([Ca2+](i)) demonstrated that both L-cysteine and NaHS reversibly suppressed glucose-induced [Ca2+](i) oscillation in a single beta-cell without obvious changes in the mean value. These substances inhibited Ca2+ - or guanosine 5'-0-3-thiotriphosphate-induced insulin release from islets permeabilized with streptolysin-O. L-cysteine and NaHS reduced ATP production and attenuated glucose-induced hyperpolarization of the mitochondrial membrane potential. Finally, L-cysteine increased H(2)S content in MIN6 cells.
    CONCLUSIONS:
    We suggest here that L-cysteine inhibits insulin release via multiple actions on the insulin secretory process through H(2)S production. Because the activities of H(2)S-producing enzymes and the tissue H(2)S contents are known to increase under diabetic conditions, the inhibition may participate in the deterioration of insulin release in this disease.
    Journal of Medicinal Chemistry, 1994, 37(8):1084-1098.
    Effects of L-Cysteine on the Oxidation Chemistry of Dopamine: New Reaction Pathways of Potential Relevance to Idiopathic Parkinson's Disease.[Reference: WebLink]
    Oxidation of the catecholaminergic neurotransmitter dopamine (1) at physiological pH normally results in formation of black, insoluble melanin polymer.
    METHODS AND RESULTS:
    In this study, it is demonstrated that L-cysteine (CySH) can divert the melanin pathway by scavenging the proximate o-quinone oxidation product of 1 to give 5-S-cysteinyldopamine (8). This cysteinyl conjugate is further oxidized in the presence of free CySH to give 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H- 1,4-benzothiazine-3-carboxylic acid (11) and its 6-S-cysteinyl (12), 8-S-cysteinyl (14), and 6,8-di-S-cysteinyl (16) conjugates in addition to many other unidentified compounds. 5-S-Cysteinyldopamine (8) and dihydrobenzothiazines 11, 12, 14, and 16 are all more easily oxidized than 1. With increasing molar excesses of CySH, the formation of melanin is decreased and, ultimately, completely blocked. Preliminary experiments have revealed that when injected into the brains of laboratory mice, dihydrobenzothiazine 11 and its cysteinyl conjugates 12 and 14 are lethal and evoke profound behavioral responses including hyperactivity and tremor. On the basis of these results and other recent observations, a new hypothesis has been advanced which might help explain the selective degeneration of nigrostriatal dopaminergic neurons which occurs in idiopathic Parkinson's Disease (PD). This hypothesis proposes that in response to some form of chronic brain insult, the activity of gamma-glutamyltranspeptidase is upregulated leading to an increased rate of translocation of glutathione (GSH) into the cytoplasm of dopaminergic cell bodies in the substantia nigra (SN) para compacta.
    CONCLUSIONS:
    The results of this in vitro study predict that such an elevated translocation of GSH into heavily pigmented dopaminergic neurons would cause a diversion of the neuromelanin pathway with consequent depigmentation of these cells and formation of 8, all of which occur in the Parkinsonian SN. The further very facile oxidation of 8 which must occur under intraneuronal conditions where 1 is autoxidized, i.e., in neuromelanin-pigmented cells, would lead to dihydrobenzothiazine 11 and its cysteinyl conjugates which could be the endotoxins responsible for the selective degeneration of dopaminergic SN neurons in PD. The ease of autoxidation of 8 is suggested to account for the low levels of this conjugate found in the degenerating and Parkinsonian SN.
    J Cardiovasc Pharmacol Ther, 2010, 15(1):53-59.
    L-cysteine stimulates hydrogen sulfide synthesis in myocardium associated with attenuation of ischemia-reperfusion injury.[Reference: WebLink]
    Hydrogen sulfide (H2S) is a biological mediator produced by enzyme-regulated pathways from L-cysteine, which is a substrate for cystathionine-γ-lyase (CSE). In myocardium, endogenously and exogenously administered H2S has been shown to protect against ischemia-reperfusion injury.
    METHODS AND RESULTS:
    We hypothesized that L-cysteine exerts its protective action through stimulation of H2S production. Rat isolated hearts were Langendorff-perfused and underwent 35-minute regional ischemia and 120-minute reperfusion. L-cysteine perfusion from 10 minutes before ischemia until 10 minutes after reperfusion limited infarct size in a concentration-dependent manner, maximal at 1 mmol/L (control 36.4% ± 2.4% vs L-cysteine 24.3% ± 3.4%, P <.05). This protective action was attenuated by the CSE inhibitor, DL-propargylglycine (PAG) 1 mmol/L (31.4 ± 5.9%, not significant vs control) but administration of the CSE cofactor pyridoxal-5-phosphate (PLP) 50 μmol/L did not enhance the effect of L-cysteine. Ten minutes normoxic perfusion with L-cysteine 1 mmol/L caused a 3-fold increase in myocardial H2S concentration (0.64 ± 0.16 vs 2.01 ± 0.07 μmol/g protein, P <.01), an effect that was significantly attenuated by PAG (1.17 ± 0.15 μmol/g protein).
    CONCLUSIONS:
    These data provide evidence that exogenous L-cysteine administration limits ischemia-reperfusion injury through a mechanism that appears to be at least partially dependent on H2S synthesis.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 8.2508 mL 41.2541 mL 82.5083 mL 165.0165 mL 206.2706 mL
    5 mM 1.6502 mL 8.2508 mL 16.5017 mL 33.0033 mL 41.2541 mL
    10 mM 0.8251 mL 4.1254 mL 8.2508 mL 16.5017 mL 20.6271 mL
    50 mM 0.165 mL 0.8251 mL 1.6502 mL 3.3003 mL 4.1254 mL
    100 mM 0.0825 mL 0.4125 mL 0.8251 mL 1.6502 mL 2.0627 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    7,2',4'-三羟基异黄酮; 2'-Hydroxydaidzein CFN97687 7678-85-5 C15H10O5 = 270.24 5mg QQ客服:2056216494
    Clematomandshurica saponin B; Clematomandshurica saponin B CFN90904 916649-91-7 C92H142O46 = 1984.10 5mg QQ客服:1413575084
    叶酸; Folic acid CFN98552 59-30-3 C19H19N7O6 = 441.4 20mg QQ客服:2159513211
    四羟基鲨稀; Tetrahydroxysqualene CFN99062 1043629-23-7 C30H50O4 = 474.7 5mg QQ客服:3257982914

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产